Gene-editing technique CRISPR identifies dangerous breast cancer mutations

$ 8.00

4.8 (715) In stock

Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope, Cancer Cell International

CRISPR – News, Research and Analysis – The Conversation – page 4

Home – Articles, Analysis, Opinion – The Conversation – page 502

New insights on CRISPR/Cas9-based therapy for breast Cancer, Genes and Environment

Breast Cancer: CRISPR Is Supercharging BRCA1 Research - The Atlantic

Are designer babies ethical? CRISPR

Home – Articles, Analysis, Opinion – The Conversation – page 502

CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology

New tool helps find genetic culprits in cancer's spread

Breast cancer – News, Research and Analysis – The Conversation – page 3

BRCA1 – News, Research and Analysis – The Conversation – page 1